Hong Kong stocks surge again | Hutchison China MediTech (02696.HK) rises over 4% again, HLX22 for gastric cancer treatment granted orphan drug designation by the European Commission.
According to the AI Finance News APP, Fuhong Hanlin (02696.HK) surged by over 4% again. As of the time of writing, it rose by 3.95% to HK$46.1, with a turnover of HK$42.2337 million.
Latest
